Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: The Israel nationwide heart failure survey

Keyphrases

• Israel 100%
• Heart Failure 100%
• Patients with Heart Failure 100%
• Late Mortality 100%
• Systolic Left Ventricular Function 100%
• Clinical Outcomes 33%
• Hospitalization 33%
• Pharmacotherapy 33%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 33%
• Treatment Strategy 33%
• Improved Outcomes 33%
• Mortality Rate 33%
• Prevalence Characteristics 33%
• Internal Medicine 33%
• Public Hospitals 33%
• Disability 33%
• Atrial Fibrillation 33%
• Angiotensin Receptor Blockers 33%
• Nationwide Survey 33%
• Digoxin 33%
• Diuretic Therapy 33%
• Systolic Function 33%
• Left Ventricular Function 33%
• Echocardiographic 33%
• Evidence-based Treatment 33%
• Cardiology Clinic 33%
• Comorbid Conditions 33%
• Reduced Systolic Function 33%
• LV Ejection Fraction 33%

Medicine and Dentistry

• Congestive Heart Failure 100%
• Heart Left Ventricle Function 100%
• Systolic Function 66%
• Internal Medicine 33%
• Prevalence 33%
• Mortality Rate 33%
• Drug Therapy 33%
• Ejection Fraction 33%
• ACE Inhibitor 33%
• Atrial Fibrillation 33%
• Angiotensin Receptor Antagonist 33%
• Diuretic Therapy 33%
• Cardiology 33%
• Digoxin 33%

Neuroscience

• ACE Inhibitor 100%
• Angiotensin Receptor 100%
• Digoxin 100%
• Atrial Fibrillation 100%
• Diuretic 100%
• Drug Therapy 100%